Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.12 EUR | +0.16% | -9.53% | -7.83% |
22/05 | Nanobiotix: strategy update, share price declines | CF |
21/05 | Nanobiotix to Transfer Phase 3 Head and Neck Cancer Study Sponsorship | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.83% | 31Cr | |
+67.53% | 6.39TCr | |
-0.77% | 4.18TCr | |
+45.66% | 4.07TCr | |
-10.72% | 2.71TCr | |
+13.30% | 2.65TCr | |
-22.79% | 1.87TCr | |
+4.70% | 1.27TCr | |
+24.10% | 1.21TCr | |
+27.41% | 1.21TCr |
- Stock Market
- Equities
- NANO Stock
- News Nanobiotix
- Nanobiotix Appoints Chief Medical Officer